Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 2 |
Apple
AAPL
|
+$949M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$788M |
| 4 |
Microsoft
MSFT
|
+$654M |
| 5 |
Broadcom
AVGO
|
+$568M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.26B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$702M |
| 3 |
Tesla
TSLA
|
+$694M |
| 4 |
Micron Technology
MU
|
+$601M |
| 5 |
Strategy Inc
MSTR
|
+$512M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.3% |
| 2 | Technology | 1.97% |
| 3 | Financials | 0.89% |
| 4 | Consumer Discretionary | 0.83% |
| 5 | Healthcare | 0.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10976
PUT
Personalis
PSNL
$1.82B
| $156K | ﹤0.01% |
27,000
+5,400
| +25% | +$24.9K |
|
10977
PLAYSTUDIOS Inc
MYPS
$60M
| $156K | ﹤0.01% |
83,883
+57,255
| +215% | +$98.1K |
|
10978
1-800-Flowers.com
FLWS
$239M
| $156K | ﹤0.01% |
+19,090
| New | +$153K |
|
10979
Sana Biotechnology
SANA
$1.18B
| $156K | ﹤0.01% |
95,676
+28,112
| +42% | +$83.8K |
|
10980
PUT
IHS Holding
IHS
$2.83B
| $156K | ﹤0.01% |
53,400
+33,000
| +162% | +$100K |
|
10981
Organogenesis Holdings
ORGO
$224M
| $156K | ﹤0.01% |
48,719
+32,339
| +197% | +$109K |
|
10982
CALL
United Microelectronic
UMC
$49.6B
| $156K | ﹤0.01% |
24,000
-30,900
| -56% | -$221K |
|
10983
CALL
BlackSky Technology
BKSY
$970M
| $155K | ﹤0.01% |
14,400
-33,800
| -70% | -$290K |
|
|
OTLY
10984
PUT
Oatly Group
OTLY
$468M
| $155K | ﹤0.01% |
11,770
-1,530
| -12% | -$22.5K |
|
10985
Escalade
ESCA
$278M
| $155K | ﹤0.01% |
+10,878
| New | +$157K |
|
|
SLI
10986
Standard Lithium
SLI
$629M
| $155K | ﹤0.01% |
106,334
-20,338
| -16% | -$37.4K |
|
10987
CALL
AirSculpt Technologies
AIRS
$187M
| $155K | ﹤0.01% |
29,900
+19,900
| +199% | +$122K |
|
10988
LifeMD
LFMD
$151M
| $155K | ﹤0.01% |
31,319
-27,689
| -47% | -$145K |
|
10989
Clarivate
CLVT
$1.29B
| $155K | ﹤0.01% |
+30,464
| New | +$175K |
|
|
DHC
10990
PUT
Diversified Healthcare Trust
DHC
$1.85B
| $155K | ﹤0.01% |
67,200
-66,200
| -50% | -$195K |
|
|
GUG
10991
Guggenheim Active Allocation Fund
GUG
$502M
| $154K | ﹤0.01% |
+10,366
| New | +$163K |
|
10992
CALL
Gossamer Bio
GOSS
$83.2M
| $154K | ﹤0.01% |
171,000
+106,900
| +167% | +$91.6K |
|
10993
Asure Software
ASUR
$262M
| $154K | ﹤0.01% |
16,331
-20,634
| -56% | -$190K |
|
|
DMYY
10994
DELISTED
dMY Squared
DMYY
| $154K | ﹤0.01% |
+14,416
| New | +$153K |
|
10995
Quad
QUAD
$519M
| $154K | ﹤0.01% |
22,048
+972
| +5% | +$6.58K |
|
10996
Outlook Therapeutics
OTLK
$156M
| $154K | ﹤0.01% |
+81,275
| New | +$334K |
|
10997
CALL
Myriad Genetics
MYGN
$302M
| $154K | ﹤0.01% |
11,200
-56,600
| -83% | -$1.04M |
|
10998
Immatics
IMTX
$1.44B
| $153K | ﹤0.01% |
21,585
+7,756
| +56% | +$66.6K |
|
|
NAK
10999
Northern Dynasty Minerals
NAK
$944M
| $153K | ﹤0.01% |
263,889
+203,213
| +335% | +$90.6K |
|
11000
CALL
Orion Group Holdings
ORN
$375M
| $153K | ﹤0.01% |
20,900
-1,300
| -6% | -$9.4K |
|
Similar funds
Jeff Yass's Q4 2024 Portfolio in Review
As of Q4 2024, Jeff Yass held 13,659 positions worth $663B, up 16% from $572B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q4 2024 filing shows 1,862 new, 5,386 increased, 4,790 reduced and 1,590 closed positions. Its largest new stake was State Street SPDR S&P 400 Mid Cap Value ETF: 1,000,000 shares worth $80.2M. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $1.26B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, down from 94% a quarter earlier, followed by Technology and Financials.
- Jeff Yass's largest Q4 2024 buy was State Street SPDR S&P 400 Mid Cap Value ETF: 1,000,000 shares worth $80.2M.
- Jeff Yass added most to Invesco QQQ Trust in Q4 2024, an estimated $1.41B increase.
- Jeff Yass's biggest Q4 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.26B.
- Jeff Yass fully exited NextEra Energy 7.299% Corporate Units in Q4 2024, selling an estimated $112M.
- Jeff Yass's ten largest holdings make up 28% of its $663B portfolio in Q4 2024.
- Jeff Yass opened 1,862 new positions and closed 1,590 in Q4 2024.
- Jeff Yass's portfolio value rose 16% quarter-over-quarter to $663B.
Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.